HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Samuel N Jacobson Selected Research

Neutropenia

9/2015Evaluation of the Hematologic Safety of Same Day Versus Standard Administration (24- to 72-Hour Delay) of Pegfilgrastim in Gynecology Oncology Patients Undergoing Cytotoxic Chemotherapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Samuel N Jacobson Research Topics

Disease

1Neoplasms (Cancer)
09/2015
1Neutropenia
09/2015
1Ovarian Neoplasms (Ovarian Cancer)
09/2015

Drug/Important Bio-Agent (IBA)

1pegfilgrastim (Neulasta)FDA Link
09/2015

Therapy/Procedure

1Drug Therapy (Chemotherapy)
09/2015